Co-proxamol

Grey

Brand Name(s):Distalgesic

Indication:All indications

Rationale:3

Considered:Apr-09

Review Date:Jul-20

Comments:
Prescribers will wish to reassess the balance of risks and benefits in each patient of continuing treatment with co-proxamol, taking into account the individual’s other medications and any comorbidities, in the light of the new US data

No new patients should start treatment with co-proxamol

MHRA Drug safety update Volume 4 Issue 6 January 2011